2024年5期
刊物介紹
本刊主要出版來自成年神經(jīng)元的轉(zhuǎn)化與再生；損傷神經(jīng)元的軸突和樹突的修復(fù)與再生；神經(jīng)再生過程中神經(jīng)元、微環(huán)境、新生血管的變化；神經(jīng)損傷后的干預(yù)、修復(fù)、保護(hù)與再生的組織形態(tài)學(xué)變化乃至細(xì)胞生物學(xué)或細(xì)胞分子生物學(xué)的改變；神經(jīng)再生研究中的新理論、新技術(shù)、新方法。NRR雜志希望成為國際神經(jīng)再生領(lǐng)域讀者、作者和專業(yè)學(xué)者最喜歡、最認(rèn)可的優(yōu)秀的專業(yè)性學(xué)術(shù)期刊。 br 期刊官方網(wǎng)站： (英文)； （中文） br 期刊投稿網(wǎng)站：
中國神經(jīng)再生研究（英文版）
Perspectives
- From the dust: extracellular vesicles as regulators of development and neuroregeneration
- Targeting epidermal growth factor receptor signaling to facilitate cortical injury repair?
- Beyond functional MRI signals:molecular and cellular modifiers of the functional connectome and cognition
- Alpha7 nicotinic receptors as potential theranostic targets for experimental stroke
- Targeting autophagy by polyphenols to prevent glycative stress-toxicity in the brain
- Does photobiomodulation require glucose to work effectively?
- Perspectives in human brain plasticity sparked by glioma invasion:from intraoperative (re) mappings to neural reconfigurations
- Anti-aquaporin-4 antibody (AQP4-IgG) and anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in the cerebrospinal fluid
- Autophagy in neuroinflammation after traumatic brain injury
- Use of induced pluripotent stem cell-derived brain cells,organoids,assembloids,and blood-brain barrier models in understanding alcohol and anesthetic-induced brain injuries:an emerging perspective
- TDP-43 is a key molecule accelerating development of Alzheimer’s disease following traumatic brain injury
- Role of lysosomal trafficking regulator in autophagic lysosome reformation in neurons: a disease perspective
- Soluble alpha-synuclein posttranslational modifications:unexpected regulators of pathological alpha-synuclein amplification
- New insights into the effects of APP gene dose on synapse in Down syndrome
- Disentangling brain PrPC proteoforms and their roles in physiology and disease
- Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics
- Perspectives for delivery of therapeutics by extravasation of biodegradable microspheres in the brain
- Mitochondria replacement from transplanted amniotic fluid stem cells: a promising therapy for nonneuronal defects in spinal muscular atrophy
- Is GDNF to Parkinson’s disease what BDNF is to Huntington’s disease?
- Protein glycation: a wolf in sweet sheep’s clothing behind neurodegeneration
- Assistive techniques and their added value for tremor classification in multiple sclerosis
- Focusing on the tetra-partite synapse in Parkinson’s disease research using human patient-derived neurons
- Two become one: combination of two risk factors in a new glaucoma animal model
- Neurological consequences of human calmodulin mutations
Reviews
- Astrocytic calcium waves: unveiling their roles in sleep and arousal modulation
- Ferroptosis: a potential therapeutic target for stroke
- Mitophagy in neurodegenerative disease pathogenesis
- NRF2 signaling cascade in amyotrophic lateral sclerosis:bridging the gap between promise and reality
- Progress in the generation of spinal cord organoids over the past decade and future perspectives
- New insights into the therapeutic approaches for the treatment of tauopathies
- Antisense therapy: a potential breakthrough in the treatment of neurodegenerative diseases
- Pathological mechanisms of amyotrophic lateral sclerosis
- Promising use of metformin in treating neurological disorders: biomarker-guided therapies
- Satellite glial cells in sensory ganglia play a wider role in chronic pain via multiple mechanisms
Research Articles
- Tumor necrosis factor-stimulated gene-6 ameliorates early brain injury after subarachnoid hemorrhage by suppressing NLRC4 inflammasome-mediated astrocyte pyroptosis
- ATAT1 deficiency enhances microglia/macrophagemediated erythrophagocytosis and hematoma absorption following intracerebral hemorrhage
- P7C3-A20 treats traumatic brain injury in rats by inhibiting excessive autophagy and apoptosis
- The miR-9-5p/CXCL11 pathway is a key target of hydrogen sulfide-mediated inhibition of neuroinflammation in hypoxic ischemic brain injury
- Endorepellin downregulation promotes angiogenesis after experimental traumatic brain injury
- Cortical activity in patients with high-functioning ischemic stroke during the Purdue Pegboard Test:insights into bimanual coordinated fine motor skills with functional near-infrared spectroscopy
- Conditioned medium from human dental pulp stem cells treats spinal cord injury by inhibiting microglial pyroptosis
- Casein kinase-2 inhibition promotes retinal ganglion cell survival after acute intraocular pressure elevation
- Translocation of telomerase reverse transcriptase coincided with ATP release in postnatal cochlear supporting cells
- Epidemiological and clinical features,treatment status,and economic burden of traumatic spinal cord injury in China: a hospital-based retrospective study
- Forebrain excitatory neuron-specific loss of Brpf1attenuates excitatory synaptic transmission and impairs spatial and fear memory
- Bromocriptine protects perilesional spinal cord neurons from lipotoxicity after spinal cord injury
- The autophagy protein Atg9 functions in glia and contributes to parkinsonian symptoms in a Drosophila model of Parkinson’s disease
- Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events:a prospective observational study